Pregnant or breastfeeding women should avoid MOTS-c given the absence of safety data in these populations, as is standard for all investigational peptide therapies
Cellular Signaling and Critical Angiogenesis Pathways Within controlled research environments, this peptide is examined for its interaction with angiogenesis-related pathways and nitric oxide (NO) modulation
In this study, the high molecular weight HA used in combination with AOD9604 may have further supported chondrocyte survival and matrix synthesis, contributing to the observed improvements in cartilage morphology and function
However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007
Allow absorption: After administering the nasal spray, allow the subject some time to naturally absorb the TB-500 formulation
Not approved for diagnostic or therapeutic purposes